A carregar...
NF‐κB/NKILA signaling modulates the anti‐cancerous effects of EZH2 inhibition
A wealth of evidence supports the broad therapeutic potential of NF‐κB and EZH2 inhibitors as adjuvants for breast cancer treatment. We contribute to this knowledge by elucidating, for the first time, unique regulatory crosstalk between EZH2, NF‐κB and the NF‐κB interacting long non‐coding RNA (NKIL...
Na minha lista:
| Publicado no: | J Cell Mol Med |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6714229/ https://ncbi.nlm.nih.gov/pubmed/31282094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14500 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|